![Brendon Buschman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 309 981 $ al 30/09/2026
Mr. Brendon Buschman, CPA, is a Chief Financial Officer at Medexus Pharmaceuticals, Inc. He received his graduate degree from Rotman School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/12/2025 | 89.538 ( 0,28 % ) | 309 981 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Director Financiero/CFO | 01/06/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Rotman School of Management
 Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medexus Pharmaceuticals, Inc.
 Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
